Pyrotinib plus Vinorelbine

DRUG2 trials

Sponsors

Chinese Academy of Medical Sciences, Sun Yat-sen University

Conditions

Brain MetastasesBreast CancerBreast DiseasesHER2-positive Breast CancerPyrotinibVinorelbine

Phase 2

A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Chinese Academy of Medical SciencesBrain Metastases, Breast Cancer

Start: 2018-12-22End: 2022-06-22Target: 30Updated: 2019-05-29

Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer

Sun Yat-sen UniversityBreast Cancer, Breast Diseases, HER2-positive Breast Cancer +2

Start: 2020-05-22End: 2023-12-01Target: 208Updated: 2022-04-26